Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
126 studies found for:    "Leishmaniasis"
Show Display Options
Rank Status Study
1 Enrolling by invitation Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Sodium Stibogluconate (SSG)
2 Completed Sodium Stibogluconate Treatment of Leishmaniasis
Condition: Leishmaniasis
Intervention: Drug: Sodium Stibogluconate (SSG)
3 Recruiting The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
Condition: Leishmaniasis
Interventions: Drug: Meglumine antimoniate;   Drug: Miltefosine;   Drug: Pentoxifylline
4 Completed Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396;   Drug: Placebo
5 Completed Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Liposomal meglumine antimoniate (Glucantime);   Drug: Liposomal meglumine antimoniate;   Drug: Liposomal Paromomycin;   Drug: Placebo
6 Completed
Has Results
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396 topical cream;   Drug: Paromomycin Alone topical cream;   Drug: Vehicle placebo cream
7 Completed Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition: Leishmaniasis, Cutaneous
Interventions: Drug: meglumine antimoniate, allopurinol;   Drug: meglumine antimoniate
8 Completed Amphotericin B Treatment in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Amphotericin B deoxycholate given as daily administration
9 Completed Liposomal Amphotericin in Disseminated Leishmaniasis
Condition: Disseminated Leishmaniasis
Intervention: Drug: Liposomal Amphotericin B
10 Not yet recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
11 Not yet recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
12 Enrolling by invitation Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Procedure: Photodynamic therapy;   Procedure: Cryotherapy
13 Completed Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Sodium Stibogluconate;   Drug: Paromomycin sulphate;   Drug: SSG and Paromomycin sulphate
14 Completed An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin
15 Completed Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: Paromomycin sulfate
16 Completed Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
Conditions: Leishmaniasis;   Cutaneous Leishmaniasis
Interventions: Drug: pentavalent antimony;   Procedure: cryotherapy;   Drug: placebo cream
17 Completed Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil
Condition: Leishmaniasis
Interventions: Drug: allopurinol;   Drug: glucantime
18 Completed Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Interventions: Drug: Meglumine antimonate;   Drug: Placebo;   Drug: Pentoxifylline
19 Completed Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
Conditions: Leishmaniasis;   Leishmaniasis, Mucocutaneous
Interventions: Drug: Miltefosine;   Drug: Standard Treatment Meglumine antimoniate
20 Not yet recruiting Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Intervention: Drug: AMBISOME

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.